Cargando…

Diagnostic value of (18)F-FDG PET-CT in detecting malignant peripheral nerve sheath tumors among adult and pediatric neurofibromatosis type 1 patients

PURPOSE: Detecting malignant peripheral nerve sheath tumors (MPNSTs) remains difficult. (18)F-FDG PET-CT has been shown helpful, but ideal threshold values of semi-quantitative markers remain unclear, partially because of variation among scanners. Using EU-certified scanners diagnostic accuracy of i...

Descripción completa

Detalles Bibliográficos
Autores principales: Geitenbeek, Ritch T. J., Martin, Enrico, Graven, Laura H., Broen, Martijn P. G., Anten, Monique H. M. E., van der Pol, Jochem A. J., Verhoef, Cornelis, Taal, Walter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860956/
https://www.ncbi.nlm.nih.gov/pubmed/35025020
http://dx.doi.org/10.1007/s11060-021-03936-y
_version_ 1784654777851838464
author Geitenbeek, Ritch T. J.
Martin, Enrico
Graven, Laura H.
Broen, Martijn P. G.
Anten, Monique H. M. E.
van der Pol, Jochem A. J.
Verhoef, Cornelis
Taal, Walter
author_facet Geitenbeek, Ritch T. J.
Martin, Enrico
Graven, Laura H.
Broen, Martijn P. G.
Anten, Monique H. M. E.
van der Pol, Jochem A. J.
Verhoef, Cornelis
Taal, Walter
author_sort Geitenbeek, Ritch T. J.
collection PubMed
description PURPOSE: Detecting malignant peripheral nerve sheath tumors (MPNSTs) remains difficult. (18)F-FDG PET-CT has been shown helpful, but ideal threshold values of semi-quantitative markers remain unclear, partially because of variation among scanners. Using EU-certified scanners diagnostic accuracy of ideal and commonly used (18)F-FDG PET-CT thresholds were investigated and differences between adult and pediatric lesions were evaluated. METHODS: A retrospective cohort study was performed including patients from two hospitals with a clinical or radiological suspicion of MPNST between 2013 and 2019. Several markers were studied for ideal threshold values and differences among adults and children. A diagnostic algorithm was subsequently developed. RESULTS: Sixty patients were included (10 MPNSTs). Ideal threshold values were 5.8 for SUVmax (sensitivity 0.70, specificity 0.92), 5.0 for SUVpeak (sensitivity 0.70, specificity 0.97), 1.7 for TLmax (sensitivity 0.90, specificity 0.86), and 2.3 for TLmean (sensitivity 0.90, specificity 0.79). The standard TLmean threshold value of 2.0 yielded a sensitivity of 0.90 and specificity of 0.74, while the standard SUVmax threshold value of 3.5 yielded a sensitivity of 0.80 and specificity of 0.63. SUVmax and adjusted SUV for lean body mass (SUL) were lower in children, but tumor-to-liver ratios were similar in adult and pediatric lesions. Using TLmean > 2.0 or TLmean < 2.0 and SUVmax > 3.5, a sensitivity and specificity of 1.00 and 0.63 can be achieved. CONCLUSION: (18)F-FDG PET-CT offers adequate accuracy to detect MPNSTs. SUV values in pediatric MPNSTs may be lower, but tumor-to-liver ratios are not. By combining TLmean and SUVmax values, a 100% sensitivity can be achieved with acceptable specificity. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11060-021-03936-y.
format Online
Article
Text
id pubmed-8860956
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-88609562022-02-23 Diagnostic value of (18)F-FDG PET-CT in detecting malignant peripheral nerve sheath tumors among adult and pediatric neurofibromatosis type 1 patients Geitenbeek, Ritch T. J. Martin, Enrico Graven, Laura H. Broen, Martijn P. G. Anten, Monique H. M. E. van der Pol, Jochem A. J. Verhoef, Cornelis Taal, Walter J Neurooncol Clinical Study PURPOSE: Detecting malignant peripheral nerve sheath tumors (MPNSTs) remains difficult. (18)F-FDG PET-CT has been shown helpful, but ideal threshold values of semi-quantitative markers remain unclear, partially because of variation among scanners. Using EU-certified scanners diagnostic accuracy of ideal and commonly used (18)F-FDG PET-CT thresholds were investigated and differences between adult and pediatric lesions were evaluated. METHODS: A retrospective cohort study was performed including patients from two hospitals with a clinical or radiological suspicion of MPNST between 2013 and 2019. Several markers were studied for ideal threshold values and differences among adults and children. A diagnostic algorithm was subsequently developed. RESULTS: Sixty patients were included (10 MPNSTs). Ideal threshold values were 5.8 for SUVmax (sensitivity 0.70, specificity 0.92), 5.0 for SUVpeak (sensitivity 0.70, specificity 0.97), 1.7 for TLmax (sensitivity 0.90, specificity 0.86), and 2.3 for TLmean (sensitivity 0.90, specificity 0.79). The standard TLmean threshold value of 2.0 yielded a sensitivity of 0.90 and specificity of 0.74, while the standard SUVmax threshold value of 3.5 yielded a sensitivity of 0.80 and specificity of 0.63. SUVmax and adjusted SUV for lean body mass (SUL) were lower in children, but tumor-to-liver ratios were similar in adult and pediatric lesions. Using TLmean > 2.0 or TLmean < 2.0 and SUVmax > 3.5, a sensitivity and specificity of 1.00 and 0.63 can be achieved. CONCLUSION: (18)F-FDG PET-CT offers adequate accuracy to detect MPNSTs. SUV values in pediatric MPNSTs may be lower, but tumor-to-liver ratios are not. By combining TLmean and SUVmax values, a 100% sensitivity can be achieved with acceptable specificity. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11060-021-03936-y. Springer US 2022-01-13 2022 /pmc/articles/PMC8860956/ /pubmed/35025020 http://dx.doi.org/10.1007/s11060-021-03936-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Clinical Study
Geitenbeek, Ritch T. J.
Martin, Enrico
Graven, Laura H.
Broen, Martijn P. G.
Anten, Monique H. M. E.
van der Pol, Jochem A. J.
Verhoef, Cornelis
Taal, Walter
Diagnostic value of (18)F-FDG PET-CT in detecting malignant peripheral nerve sheath tumors among adult and pediatric neurofibromatosis type 1 patients
title Diagnostic value of (18)F-FDG PET-CT in detecting malignant peripheral nerve sheath tumors among adult and pediatric neurofibromatosis type 1 patients
title_full Diagnostic value of (18)F-FDG PET-CT in detecting malignant peripheral nerve sheath tumors among adult and pediatric neurofibromatosis type 1 patients
title_fullStr Diagnostic value of (18)F-FDG PET-CT in detecting malignant peripheral nerve sheath tumors among adult and pediatric neurofibromatosis type 1 patients
title_full_unstemmed Diagnostic value of (18)F-FDG PET-CT in detecting malignant peripheral nerve sheath tumors among adult and pediatric neurofibromatosis type 1 patients
title_short Diagnostic value of (18)F-FDG PET-CT in detecting malignant peripheral nerve sheath tumors among adult and pediatric neurofibromatosis type 1 patients
title_sort diagnostic value of (18)f-fdg pet-ct in detecting malignant peripheral nerve sheath tumors among adult and pediatric neurofibromatosis type 1 patients
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860956/
https://www.ncbi.nlm.nih.gov/pubmed/35025020
http://dx.doi.org/10.1007/s11060-021-03936-y
work_keys_str_mv AT geitenbeekritchtj diagnosticvalueof18ffdgpetctindetectingmalignantperipheralnervesheathtumorsamongadultandpediatricneurofibromatosistype1patients
AT martinenrico diagnosticvalueof18ffdgpetctindetectingmalignantperipheralnervesheathtumorsamongadultandpediatricneurofibromatosistype1patients
AT gravenlaurah diagnosticvalueof18ffdgpetctindetectingmalignantperipheralnervesheathtumorsamongadultandpediatricneurofibromatosistype1patients
AT broenmartijnpg diagnosticvalueof18ffdgpetctindetectingmalignantperipheralnervesheathtumorsamongadultandpediatricneurofibromatosistype1patients
AT antenmoniquehme diagnosticvalueof18ffdgpetctindetectingmalignantperipheralnervesheathtumorsamongadultandpediatricneurofibromatosistype1patients
AT vanderpoljochemaj diagnosticvalueof18ffdgpetctindetectingmalignantperipheralnervesheathtumorsamongadultandpediatricneurofibromatosistype1patients
AT verhoefcornelis diagnosticvalueof18ffdgpetctindetectingmalignantperipheralnervesheathtumorsamongadultandpediatricneurofibromatosistype1patients
AT taalwalter diagnosticvalueof18ffdgpetctindetectingmalignantperipheralnervesheathtumorsamongadultandpediatricneurofibromatosistype1patients